MESA LABORATORIES INC /CO/ - Common Stock, no par value (MLAB)
CUSIP: 59064R109
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 5,555,932
- Total 13F shares
- 4,981,288
- Share change
- -206,514
- Total reported value
- $333,781,447
- Price per share
- $67.01
- Number of holders
- 139
- Value change
- -$17,563,084
- Number of buys
- 65
- Number of sells
- 93
Quarterly Holders Quick Answers
What is CUSIP 59064R109?
CUSIP 59064R109 identifies MLAB - MESA LABORATORIES INC /CO/ - Common Stock, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 59064R109:
Top shareholders of MLAB - MESA LABORATORIES INC /CO/ - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.9%
from 13D/G
|
791,127
|
$74,539,987 | — | 30 Jun 2025 | |
| Conestoga Capital Advisors, LLC |
13D/G
13F
|
Conestoga Capital Advisors · Company |
11%
|
618,111
|
$71,997,569 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7%
|
389,409
|
$36,690,115 | — | 30 Jun 2025 | |
| ROYCE & ASSOCIATES LP |
13D/G
13F
|
Company |
5%
|
271,118
|
$31,579,825 | -$1,874,047 | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
3.9%
|
218,796
|
$20,614,989 | — | 30 Jun 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
3.9%
|
214,290
|
$20,190,404 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
211,835
|
$19,959,094 | — | 30 Jun 2025 | |
| GENEVA CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.6%
|
199,092
|
$18,758,414 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
3.3%
|
185,555
|
$17,483,032 | — | 30 Jun 2025 | |
| Glenmede Investment Management, LP |
13F
|
Company |
2.6%
|
142,508
|
$13,427,102 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
138,769
|
$13,075,752 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.1%
|
115,284
|
$10,864,493 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2%
|
113,285
|
$10,674,112 | — | 30 Jun 2025 | |
| Select Equity Group, L.P. |
13F
|
Company |
1.8%
|
102,198
|
$9,629,096 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.7%
|
92,732
|
$8,737,210 | — | 30 Jun 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.6%
|
90,479
|
$8,524,931 | — | 30 Jun 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
1.4%
|
79,476
|
$7,488,271 | — | 30 Jun 2025 | |
| John Bradley Schmieder |
3/4/5
|
Director |
—
class O/S missing
|
62,760
|
$7,051,714 | — | 14 Sep 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.3%
|
73,513
|
$6,926,394 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
68,027
|
$6,409,504 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
64,928
|
$6,117,515 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
61,764
|
$5,819,404 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
57,710
|
$5,437,436 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.96%
|
53,497
|
$5,040,480 | — | 30 Jun 2025 | |
| CRAWFORD INVESTMENT COUNSEL INC |
13F
|
Company |
0.93%
|
51,744
|
$4,875,320 | — | 30 Jun 2025 | |
| COMERICA BANK |
13F
|
Company |
0.8%
|
44,263
|
$4,170,474 | — | 30 Jun 2025 | |
| DIAMOND HILL CAPITAL MANAGEMENT INC |
13F
|
Company |
0.7%
|
38,799
|
$3,655,642 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.67%
|
37,278
|
$3,511,000 | — | 30 Jun 2025 | |
| Meros Investment Management, LP |
13F
|
Company |
0.66%
|
36,618
|
$3,450,148 | — | 30 Jun 2025 | |
| MESA LABORATORIES INC /CO/ |
3/4/5
|
Director |
—
mixed-class rows
|
29,818
mixed-class rows
|
$3,350,351 | — | 15 Jun 2022 | |
| Evan Guillemin |
3/4/5
|
Director |
—
mixed-class rows
|
29,297
mixed-class rows
|
$3,281,699 | — | 01 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.56%
|
31,294
|
$2,948,521 | — | 30 Jun 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.54%
|
29,778
|
$2,805,684 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.53%
|
29,426
|
$2,772,520 | — | 30 Jun 2025 | |
| John Sakys |
3/4/5
|
CFO |
—
mixed-class rows
|
49,530
mixed-class rows
|
$2,566,577 | -$62,350 | 21 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.48%
|
26,873
|
$2,531,974 | — | 30 Jun 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.46%
|
25,346
|
$2,388,100 | — | 30 Jun 2025 | |
| BBR PARTNERS, LLC |
13F
|
Company |
0.45%
|
25,195
|
$2,373,873 | — | 30 Jun 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.45%
|
25,156
|
$2,370,198 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.4%
|
22,471
|
$2,117,218 | — | 30 Jun 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.37%
|
20,483
|
$1,929,882 | — | 30 Jun 2025 | |
| KING LUTHER CAPITAL MANAGEMENT CORP |
13F
|
Company |
0.36%
|
19,921
|
$1,876,957 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.36%
|
19,898
|
$1,874,790 | — | 30 Jun 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.33%
|
18,528
|
$1,745,708 | — | 30 Jun 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.33%
|
18,287
|
$1,723,001 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.33%
|
18,143
|
$1,709,384 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
17,795
|
$1,676,644 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.31%
|
17,403
|
$1,639,711 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.29%
|
15,924
|
$1,500,359 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.26%
|
14,657
|
$1,380,982 | — | 30 Jun 2025 |
Institutional Holders of MESA LABORATORIES INC /CO/ - Common Stock, no par value (MLAB) as of Q3 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.